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Tissue inhibitor of metalloproteinase 3 (TIMP-3) is
an important regulator of extracellular matrix (ECM)
turnover. TIMP-3binds to sulfatedECMglycosamino-
glycans or is endocytosed by cells via low-density
lipoprotein receptor-related protein 1 (LRP-1). Here,
we report that heparan sulfate (HS) and chondroitin
sulfate E (CSE) selectively regulate postsecretory
trafficking of TIMP-3 by inhibiting its binding to
LRP-1. HS and CSE also increased TIMP-3 affinity
for glycan-binding metalloproteinases, such as ada-
malysin-like metalloproteinase with thrombospondin
motifs 5 (ADAMTS-5), by reducing the dissociation
rate constants. The sulfation pattern was crucial for
these activities because monosulfated or truncated
heparin had a reduced ability to bind to TIMP-3 and
increase its affinity for ADAMTS-5. Therefore, sulfa-
tionof ECMglycans regulates the levels and inhibitory
activity of TIMP-3 and modulates ECM turnover, and
small mimicries of sulfated glycans may protect the
tissue from the excess destruction seen in diseases
such as osteoarthritis, cancer, and atherosclerosis.
INTRODUCTION
Tissue inhibitor of metalloproteinases 3 (TIMP-3) is unique
among the family of mammalian TIMPs in that it binds to the
extracellular matrix (ECM), whereas the other TIMPs (TIMP-1,
TIMP-2, and TIMP-4) diffuse freely in the extracellular environ-
ment (Blenis and Hawkes, 1983; Brew and Nagase, 2010). This
ECM-binding ability is thought to position TIMP-3 as a major in-
hibitor of ECM turnover, and Timp3-null mice exhibit a range of
phenotypes associated with increased ECM degradation. For
example, the mice show increased collagen degradation in the
lungs, leading to increased alveolar size, impaired lung function,
and reduced life span (Leco et al., 2001). Additional phenotypes1300 Chemistry & Biology 21, 1300–1309, October 23, 2014 ª2014 Tassociated with increased ECM degradation include elevated
epithelial apoptosis upon mammary gland involution (Fata
et al., 2001), impaired bronchiole branching morphogenesis
(Gill et al., 2006), cardiac hypertrophy (Fedak et al., 2004),
increased cardiac remodeling after myocardial infarction
(Tian et al., 2007), and accelerated spontaneous osteoarthritis
(Sahebjam et al., 2007).
Although ECM binding is a distinguishing feature of TIMP-3,
the molecular mechanism and functional consequences of
ECM binding remain unknown. Yu et al. (2000) showed that
TIMP-3 can be solubilized from uterine tissue by adding sulfated
glycosaminoglycans such as heparin, heparan sulfate, and
chondroitin sulfates. TIMP-3 has also been shown to bind to
heparin in vitro, leading the authors to suggest that TIMP-3 binds
to sulfated glycosaminoglycans (sGAGs) in the ECM. This was
supported by Lee et al. (2007), who identified a highly basic re-
gion on the surface of TIMP-3 that, they postulated, interacts
with negatively charged sulfated ECM components. By mutation
of this basic region, they generated a soluble mutant of TIMP-3
that did not bind to the ECM. However, although it is generally
accepted that TIMP-3 binds to sGAG in the ECM, it is not known
to which specific sGAG TIMP-3 binds and whether specific pro-
teoglycans carry the TIMP-3-binding sGAG.
TIMP-3 secreted from the cell can be cleared from the extra-
cellular environment through cellular uptake and degradation
mediated by the endocytic receptor low-density lipoprotein
receptor-related protein 1 (LRP-1) (Scilabra et al., 2013; Troe-
berg et al., 2008). It is unclear what determines postsecretory
trafficking of TIMP-3 to the ECM or to endocytosis and how
this balance is regulated in health and disease. Although several
factors regulate TIMP-3 transcription, posttranslational regula-
tory mechanisms appear to be central in determining TIMP-3
availability (Troeberg et al., 2008). Reduced tissue levels of
TIMP-3 are associated with several pathological conditions,
such as osteoarthritis (Morris et al., 2010), cancer (Cruz-Munoz
and Khokha, 2008), and atherosclerosis (Cardellini et al., 2009).
Therefore, identification of themolecular determinants that regu-
late TIMP-3 trafficking in the extracellular environment is impor-
tant to understand both physiological and pathological ECM
degradation.he Authors
Figure 1. TIMP-3 Binds to Highly Sulfated
Glycosaminoglycans
Glycosaminoglycan-binding multiwell plates were
coated with 10 mg/ml PPS, heparin, HS, DS,
aggrecan, hyaluronic acid (HA), squid CSE, bonito
CSE, C-4-S, or C-6-S. Wells were then incubated
with TIMP-3-FLAG, and bound TIMP-3 was
detected using M2 anti-FLAG primary antibody
and a horseradish peroxidase-coupled secondary
antibody.
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TIMP-3 binds and to determine their effects on TIMP-3 traf-
ficking and affinity for target metalloproteinases.
RESULTS
TIMP-3 Binds to Heparan Sulfate and Chondroitin
Sulfate E
Using a solid-phase binding assay, we investigated TIMP-3
binding to several glycosaminoglycans. TIMP-3 bound strongly
to highly sulfated heparin (12.5 kDa, KD = 19 ± 4 nM) and to
pentosan polysulfate (PPS, 4.7 kDa, KD = 3 ± 0.4 nM), a highly
sulfated polyxylan generated by chemical sulfation of cellulose
(Figure 1). TIMP-3 had a comparable affinity for the natural matrix
glycan heparan sulfate (HS, 22 kDa), with a KD of 29 ± 18 nM.
TIMP-3 also bound strongly to chondroitin sulfate E (CSE), a
4,6-O-disulfated glycan. TIMP-3 had a higher affinity for CSE
from squid (50 kDa, KD = 10 ± 1 nM) than for CSE from bonito
(8.7 kDa, KD = 39 ± 6 nM) (Figure 1). No binding to dermatan sul-
fate, aggrecan, hyaluronic acid, chondroitin-4-sulfate (C-4-S), or
chondroitin-6-sulfate (C-6-S) was detected.
HS and CSE Block TIMP-3 Endocytosis by LRP-1
The effect of HS and CSE on TIMP-3 endocytosis by LRP-1 was
investigated by adding recombinant TIMP-3 to HTB94 chondro-
sarcoma cells and following its disappearance from the medium
by immunoblotting. TIMP-3 was taken up by the cells with a half-
life of 5 hr, and this endocytosis was inhibited by an LRP ligand
binding antagonist, receptor-associated protein (RAP) (Figures
2A and 2B). Endocytosis was also inhibited by preincubation of
TIMP-3 with heparin, HS, or bonito CSE, whereas C-4-S had
no effect (Figures 2A and 2B).
Little endogenous TIMP-3 was found in the culture medium of
HTB94 cells, but TIMP-3 accumulated in the medium when cells
were treated with CSE or HS (Figure 2C), indicating that they
blocked endocytosis of endogenous TIMP-3. The amount of
TIMP-3 detected was comparable with that seen in the presence
of heparin and RAP. No TIMP-3 accumulated in the medium of
cells treated with C-4-S.
Recombinant TIMP-3 bound to the ectodomain of LRP-1 with
a KD value of 28 ± 6 nM (Figure 2D). This binding was completely
inhibited by preincubation of TIMP-3 with squid CSE and
partially inhibited by bonito CSE, heparin, and HS.
HS and CSE Increase TIMP-3 Affinity for ADAMTS-5
We evaluated the effect of HS and CSE on TIMP-3 affinity for
ADAMTS-5. In the absence of sGAGs, a Ki value of 1.36 ±
0.02 nM was calculated for TIMP-3 inhibition of ADAMTS-5 (Fig-Chemistry & Bure 3A), in agreement with previous reports (Troeberg et al.,
2009, 2012). Addition of PPS (0.4 mg/ml, equivalent to 100 nM
of 4.7 kDa polysaccharide or 2 mM disaccharide) improved the
affinity between ADAMTS-5 and TIMP-3 so that even 0.5 nM
ADAMTS-5was fully inhibited by 0.5 nMTIMP-3 (Figure 3A), indi-
cating a substantial affinity increase. We were unable to accu-
rately determine the improved Ki because we could not measure
the activity of lower enzyme concentrations, but, by fitting the
data to the tight-binding equation (Bieth, 1995), we estimated
that Ki is approximately 1 pM, a 1000-fold improvement.
Ki was similarly improved by addition of HS (8 mg/ml, equiva-
lent to 1 mM of 22 kDa polysaccharide or 13 mM disaccharide)
or heparin (1 mg/ml, equivalent to 100 nM of 12.5 kDa polysac-
charide or 2 mM disaccharide) (Figure 3A) and also by CSE
from bonito (1 mg/ml, equivalent to 100 nM of 8.7 kDa polysac-
charide or 1.5 mM disaccharide) or squid (8 mg/ml, equivalent
to 100 nM of 50 kDa polysaccharide or 8.3 mM disaccharide)
(Figure 3B).
To compare their efficacies, increasing concentrations of HS
and CSE were added to a fixed concentration of TIMP-3 and
ADAMTS-5. Concentrations are expressed as molarity of disac-
charide to allow comparison between HS and CSE of greatly
differing lengths. At concentrations near a Ki of 1.36 nM, TIMP-
3 only partially inhibited ADAMTS-5. Therefore, 0.5 nM TIMP-3
inhibited only 20% of the activity of 0.5 nM ADAMTS-5 (Fig-
ure 3A). At concentrations above 0.1 mM disaccharide, PPS
improved the affinity between TIMP-3 and ADAMTS-5 so that
0.5 nM TIMP-3 completely inhibited 0.5 nM ADAMTS-5 (Fig-
ure 3C). The affinity was increased similarly by heparin and HS
at disaccharide concentrations above 10 and 100 mM, respec-
tively. CSE was similarly effective above 10 mM disaccharide,
although bonito CSE (8.7 kDa) was less effective than squid
CSE of 50, 200, or 800 kDa at lower concentrations.
HS and CSE Reduce the Dissociation Rate of the
TIMP-3-ADAMTS-5 Complex
Biolayer interferometry was used to further explore the mecha-
nism by which sGAGs increase ADAMTS-5-TIMP-3 affinity.
ADAMTS-5 bound to immobilized biotinylated TIMP-3 with a
KD of 72 ± 7 nM (Figure 4A). In accordance with previous exper-
iments (Troeberg et al., 2002), this is higher than the Ki calculated
in solution, most likely because of the effects of TIMP-3 immobi-
lization. The koff value was determined as 23 ± 0.23 0
3 s1 and
the kon rate as 1.41 3 10
4 M-1.s-1.
Addition of sGAG markedly reduced the dissociation rate of
the ADAMTS-5-TIMP-3 complex (Figure 4B) so that it was not
possible to determine a value for koff using this method. Squid
CSE and PPS stabilized the complex to the extent that noiology 21, 1300–1309, October 23, 2014 ª2014 The Authors 1301
Figure 2. Sulfated Glycosaminoglycans
Block LRP-1-Mediated Endocytosis of
TIMP-3
(A) HTB94 chondrosarcoma cells were incubated
in serum-free DMEM with recombinant TIMP-3-
FLAG (0.5 nM) either alone (control) or in the
presence of RAP (1 mM), heparin (200 mg/ml), HS
(200 mg/ml), C-4-S (200 mg/ml), or bonito CSE
(200 mg/ml). TIMP-3 remaining in the medium was
detected by immunoblotting using M2 anti-FLAG
antibody.
(B) TIMP-3 remaining in themedium of cells shown
in (A) was quantified using Phoretix 1D software.
Symbols indicate TIMP-3 alone (B) or with C-
4-S (;), HS (,), heparin (C), bonito CSE (A), or
RAP (:).
(C) HTB94 chondrosarcoma cells were incubated
in serum-free DMEM containing RAP (0.5 and
0.75 mM), heparin (100 and 200 mg/ml), HS (100
and 200 mg/ml), C-4-S (100 and 200 mg/ml), or
bonito CSE (100 and 200 mg/ml). Accumulation of
endogenous TIMP-3 in the medium was detected
by immunoblotting using a rabbit anti-TIMP-3
antibody.
(D) LRP-1 (5 nM) was coated onto a microtiter
plate and wells blocked with 3% (m/v) bovine
serum albumin in TIMP buffer. Wells were then
incubated with TIMP-3-FLAG (control) or with
TIMP-3-FLAG preincubated for 1 hr at 37C
with heparin, HS, bonito CSE, or squid CSE
(200 mg/ml). Bound TIMP-3-FLAG was detected
using M2 anti-FLAG antibody.
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ciation was observed with bonito CSE and HS.
sGAG had a lesser effect on association of TIMP-3 and
ADAMTS-5, with the association rate increasing from 2.13 ±
0.02 M-1.s-1 in the absence of sGAG to 4.81 ± 0.03 M-1.s-1 in
the presence of HS and 5.68 ± 0.04 M-1.s-1 in the presence of
squid CSE.
Heparin of dp14 and Longer Increases Affinity
We investigated theminimumchain length required for sGAGac-
tivity using heparin of differing sizes. TIMP-3 bound strongly to
heparin with a degree of polymerization of 36 (dp36, 12.5 kDa)
as well as to heparin of dp14 (5 kDa) and dp9 (3 kDa), with KD
values of 2 nM for all three heparin sizes (Figure 5A). TIMP-3
binding to dp5 heparin (1.7 kDa) was undetectable. Similarly,
ADAMTS-5 bound strongly to heparin of dp36, dp14, and dp9,
with KD values of 10 nM for all three sizes (Figure 5B), and binding
to dp5 heparin was undetectable.
Heparin of dp36 and dp14 effectively increased TIMP-3-
ADAMTS-5 affinity, whereas heparins of dp9 and dp5 were
ineffective at disaccharide concentrations of 1 mM (Figure 5C).
Although dp9 heparin bound strongly to both proteins, it was un-
able to increase their affinities. This is most likely due to the lack
of sufficient length to bridge the binding sites on the two proteins
to form a high-affinity trimolecular complex.
The ability of heparin to block interaction between TIMP-3 and
LRP-1 also depended on length. Heparins of dp36, dp14, and
dp9 caused the accumulation of endogenous TIMP-3 in HTB94
cells, whereas dp5 heparin was ineffective (data not shown).1302 Chemistry & Biology 21, 1300–1309, October 23, 2014 ª2014 THeparin Sulfation Is Required for Affinity Increase and
Endocytosis
Using heparin of dp36, we examined the influence of sGAG
sulfation. TIMP-3 bound to heparin with an estimated KD of
2 nM. 2-O-desulfation and N-desulfation increased the KD to 4
and 5 nM, respectively. 6-O-desulfation decreased affinity the
most, with a KD too high to be determined (Figure 5D).
ADAMTS-5 bound to heparin with an estimated KD of 9 nM.
2-O-desulfation had little effect on binding (KD of 12 nM),
whereas N-desulfation and 6-O-desulfation decreased affinity
themost, and the KD could not be determined (Figure 5E). There-
fore, 6-O-desulfation had the greatest effect on binding to both
proteins, and 2-O-desulfation had the least effect.
N-desulfation, 2-O-desulfation, and 6-O-desulfation all abla-
ted the ability of heparin to increase the affinity between
TIMP-3 and ADAMTS-5, with no improvement in affinity seen
at up to 2 mM disaccharide. For 6-O-desulfated heparin, this
correlated with a substantial reduction in binding to both pro-
teins. 2-O-desulfated heparin had only a small reduction in
binding to each protein (KD reduced from 2 to 4 nM for TIMP-
3 and from 9 to 12 nM for ADAMTS-5) but greatly affected
the ability to increase the affinity between the two proteins
(Figure 5F). This indicates that disulfation is critical for this trimo-
lecular interaction.
TIMP-3 accumulated in the medium of cells treated with 2-O-
desulfated and N-desulfated heparin but not in those treated
with 6-O-desulfated heparin (data not shown). Therefore, the
ability to block TIMP-3 endocytosis by LRP-1 correlated with
the ability to bind to the inhibitor.he Authors
Figure 3. sGAGs Increase TIMP-3 Affinity
for ADAMTS-5
(A) ADAMTS-5 (0.5 nM) was incubated with TIMP-
3 (0.5–10 nM, 1 hr, 37C) in TIMP buffer alone (B)
or with HS (,, 1 mM of 8 kDa polysaccharide and
13 mM disaccharide), heparin (C, 100 nM of
12.5 kDa polysaccharide and 2 mM disaccharide),
or PPS (6, 100 nM of 4.7 kDa polysaccharide and
0.8 mM disaccharide), and the residual ac-
tivity against fluorescent peptide substrate was
determined.
(B) ADAMTS-5 (0.5 nM) was incubated with TIMP-
3 (0.5–10 nM, 1 hr, 37C) in TIMP buffer alone (B)
or with bonito CSE (A, 100 nM of 8.7 kDa poly-
saccharide and 1.5 mMdisaccharide) or squid CSE
(7, 100 nM of 50 kDa polysaccharide and 8.3 mM
disaccharide), and the residual activity against the
fluorescent peptide substrate was determined.
(C) TIMP-3 (0.5 nM) was incubated with ADAMTS-
5 (0.5 nM) and various concentrations of HS (108–
104 M disaccharide), heparin (108–105 M
disaccharide), or PPS (109–104 M disaccharide)
(1 hr, 37C). The residual activity against the fluo-
rescent peptide substrate was determined.
(D) TIMP-3 (0.5 nM) was incubated with ADAMTS-
5 (0.5 nM) and various concentrations of bonito
CSE (1011–105 M disaccharide), squid CSE
fraction 1 (108–105 M disaccharide), squid CSE
fraction 2 (1012–105 M disaccharide), or squid
CSE fraction 3 (1012–105 M disaccharide) (1 hr,
37C). The residual activity against the fluorescent
peptide substrate was determined.
Chemistry & Biology
Matrix Glycans Augment TIMP-3 Levels and ActivityEffect of Heparin Ring Integrity on Affinity Increase
Periodate-treated, glycol-split dp36 heparin bound to TIMP-3
and ADAMTS-5 as well as untreated heparin (Figures 5G and
5H) and was also effective at increasing ADAMTS-5-TIMP-3
affinity (Figure 5I) and blocking TIMP-3 endocytosis (data not
shown).
TIMP-3 Colocalizes with Perlecan
We stained for TIMP-3 in cartilage, a tissue with an ECM rich
in multiple sGAGs. TIMP-3 colocalized with the HS-bearing pro-
teoglycan perlecan in the pericellular matrix of femoral head
cartilage (Figure 6A). This staining was absent in Timp3/
mice, confirming the specificity of the immunolocalization.
Perlecan colocalization with TIMP-3 was also observed in the
pericellular matrix of knee cartilage from adult mice (Figure 6B).
Cartilage Contains CSE
Perlecan is well established to be an HS-containing proteo-
glycan. We investigated whether CS containing E-type disac-
charide units is also present in cartilage by analyzing the
disaccharide composition of cartilage CS. Both human and
porcine adult cartilage contained the N-acetylgalactosamine
4,6-O-disulfate (DDi-diSE) unit characteristic of CSE (Table 1).Chemistry & Biology 21, 1300–1309, OAs expected, given the abundance of
aggrecan in cartilage, the majority of CS
was either 4-sulfated (27% in human
cartilage, 56% in porcine cartilage) or 6-
sulfated (63% in human cartilage, 33%in porcine cartilage). The E-type disaccharide unit made up 3%
of the total CS in human cartilage and 1% in porcine cartilage.
DISCUSSION
TIMP-3 has long been known to bind to the ECM, with this local-
ization thought to position it optimally for inhibition of ECM-
degrading metalloproteinases. In this study, we show that the
matrix not only serves to maintain a reservoir of TIMP-3 but
that it directly modulates TIMP-3 inhibitory activity and blocks
its endocytic uptake and cellular degradation.
TIMP-3 is thought to bind to sGAG in the ECM (Yu et al., 2000),
but the specific TIMP-3-binding glycosaminoglycans and the
proteoglycan(s) bearing these moieties have remained unidenti-
fied, largely because of the difficulties associated with expres-
sion, purification, and biochemical analysis of TIMP-3. Following
our elucidation that the inhibitor is cleared rapidly from the
medium of cultured cells by LRP-1-mediated endocytosis (Troe-
berg et al., 2008; Scilabra et al., 2013), we used a strategy of
blocking endocytosis to purify sufficient recombinant TIMP-3
for such analyses and showed that HS and CS chains containing
E-type disaccharide units are likely to be the physiological TIMP-
3-binding sGAGs in the ECM. In cartilage, we found that TIMP-3ctober 23, 2014 ª2014 The Authors 1303
Figure 4. Biolayer Interferometry Analysis
Showing that sGAGs Reduce Dissociation
of the TIMP-3-ADAMTS-5 Complex
(A) Streptavidin tips were coated with biotinylated
TIMP-3, and binding of ADAMTS-5 (20–500 nM)
was analyzed by biolayer interferometry.
(B) Streptavidin tips coated with biotinylated
TIMP-3 were incubated with ADAMTS-5 (200 nM)
and TIMP buffer (no GAG), HS (100 mM), bonito
CSE (10 mM), PPS (100 nM), or squid CSE (10 mM)
in TIMP buffer. Binding was analyzed by biolayer
interferometry.
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in this tissue, perlecan is likely to be the proteoglycan respon-
sible for TIMP-3 retention. Perlecan is primarily thought of as
an HS proteoglycan (Hassell et al., 1980), but it can also bear
CS (SundarRaj et al., 1995), dermatan sulfate (DS) (Couchman
et al., 1996), or keratan sulfate (Knox et al., 2005). Of particular
interest, perlecan has been reported to carry CSE in bovine carti-
lage (Kvist et al., 2006). In this study, we found that the E-type CS
disaccharide unit is also present in adult human and porcine
cartilage. Perlecan may also mediate TIMP-3 binding to the
ECM in other locations, such as in the basement membrane,
and other HS- and CSE-bearing proteoglycans may bind
TIMP-3 in other tissues. In cartilage, perlecan is exclusively
localized in the pericellular matrix (Iozzo et al., 1994), where
it binds several growth factors and regulatory molecules. For
example, FGF-2 bound to the HS chains of perlecan transduces
mechanical stimuli to chondrocytes (Vincent et al., 2007). Perle-
can expression increases in osteoarthritis (OA) cartilage (Tesche
andMiosge, 2004), but its sulfation status in disease is unknown.
TIMP-3 levels are primarily regulated posttranslationally, and
the inhibitor is cleared from the extracellular environment by
the endocytic receptor LRP-1 (Scilabra et al., 2013). Heparin
blocks TIMP-3 binding to LRP-1 and inhibits cellular endocy-
tosis, suggesting that the LRP-1 binding site overlaps with the
ECM-binding site, identified by Lee et al. (2007) as an extended
patch of basic residues. Here we show that HS and CSE similarly
block TIMP-3 binding to LRP-1 and inhibit its endocytosis. Extra-
cellular trafficking of TIMP-3 is therefore regulated by the
balance between matrix binding and endocytosis, and factors
altering either matrix sulfation or the endocytic capacity of the
cell will shift this balance. A number of other LRP-1 ligands
also bind to sGAGs. For example, midkine, connective tissue
growth factor, MMP-13, MMP-2, MMP-9, ADAMTS-4, and
ADAMTS-5 are all LRP-1 ligands (Lillis et al., 2008; Yamamoto
et al., 2013, 2014) that have been shown to bind to heparin
in vitro. This suggests that the model outlined here may not be
unique to TIMP-3 and that extracellular levels of many bioactive
molecules that bind to the ECM may be regulated by the inter-
play between matrix binding and LRP-1-mediated endocytosis.
This positions ECM sulfation as a potential key regulator of the
ECM proteome.
In addition to blocking LRP-1-mediated endocytosis, HS
and CSE increased TIMP-3 affinity for ADAMTS-5. We estimate
that affinity was increased by 1000-fold, indicating that the
sGAGs are likely to have induced a conformational change in
one or both of the proteins. PPS similarly increases TIMP-3 affin-
ity for ADAMTS-4 (Troeberg et al., 2012), so HS and CSE are1304 Chemistry & Biology 21, 1300–1309, October 23, 2014 ª2014 Tlikely to increase TIMP-3 affinity for other target metalloprotei-
nases that bind to sGAG. Such enzymes are also likely to interact
with the ECM, indicating that this mechanism selectively aug-
ments TIMP-3 inhibition of enzymes it is likely to encounter in
the ECM environment. Target metalloproteinases that do not
bind sGAG, including many MMPs, would escape this increase
in affinity.
HS and CSE are the two most highly sulfated among the ECM
sGAGs we tested, and sulfation is likely to be critical for their
binding ability. Indeed, only disulfated CSE bound to TIMP-3,
whereas monosulfated C-4-S and C-6-S did not. Although 2-
O-desulfation did not greatly affect heparin binding to TIMP-3
or ADAMTS-5, it abolished the ability of heparin to increase the
affinity between the two proteins. This indicates that the effects
of the ECM on TIMP-3 may be altered under conditions that
change sulfation. In cartilage, changes in sulfation have primarily
focused on the most abundant proteoglycan, aggrecan. No data
are available on changes in HS or CSE sulfation in cartilage with
age or disease, but several potential mechanisms for eliciting
such changes have been proposed. For example, expression
of several HS-synthesizing enzymes is altered during inflamma-
tion (Krenn et al., 2008), and cartilage expression of the HS
sulfatases Sulf-1 and Sulf-2 is increased with aging and in OA
(Otsuki et al., 2008), with Sulf-null mice developing OA more
rapidly (Otsuki et al., 2010). Studies on HS and CSE sulfation in
cartilage are clearly warranted, given their important role in regu-
lating the amount and activity of TIMP-3 as well as other regula-
tory proteins, such as FGF-2, CTGF, midkine, ADAMTS-4, and
ADAMTS-5. Interestingly, TIMP-3 staining in the ECM of renal
and pulmonary blood vessels increases with age (Macgregor
et al., 2009), with the authors postulating that the TIMP-3-binding
capacity of the ECM may be increased by age-related changes
in glycosylation.
CSE, containing the disulfated N-acetylgalactosamine 4,6-
O-disulfate residue, was initially isolated from squid cartilage
(Kawai et al., 1966) but has since been isolated from numerous
mammalian sources. Its disulfated status confers CSE with a
binding activity more similar to heparin than to monosulfated
C-4-S or C-6-S. CSE has been shown to interact with a number
of growth factors, including midkine (Deepa et al., 2002), pleio-
trophin (Deepa et al., 2002), several fibroblast growth factors
(Asada et al., 2009; Deepa et al., 2002), heparin-binding
epidermal growth factor (Deepa et al., 2002), brain-derived neu-
rotrophic factor, and bone morphogenetic protein 4 (Miyazaki
et al., 2008). CSE is particularly abundant in the brain (Ueoka
et al., 2000), where it is thought to play a role in brain develop-
ment (Purushothaman et al., 2007), neurite outgrowth (Sotogakuhe Authors
Figure 5. Size and Sulfation Affect the Hep-
arin-Mediated Increase in TIMP-3 Affinity
for ADAMTS-5
(A and B) Heparin (60 mM disaccharide) of dp36
(12.5 kDa), dp14 (5 kDa), dp9 (3 kDa), or dp5
(1.7 kDa) was immobilized on glycosaminoglycan-
binding multiwell plates. The wells were then
incubatedwith FLAG-tagged TIMP-3 (0.08–10 nM)
(A) or FLAG-tagged ADAMTS-5 (0.3–20 nM) (B).
Bound protein was detected using M2 anti-FLAG
primary antibody and a horseradish peroxidase-
coupled secondary antibody.
(C) TIMP-3 (0.5 nM) and ADAMTS-5 (0.5 nM) were
incubated (1 hr, 37C) with various concentrations
(1–2000 nM disaccharide) of heparin with dp36,
dp14, dp9, or dp5. The residual activity against the
fluorescent peptide substrate was determined.
(D and E) Heparin (60 mM disaccharide) of dp36
(12.5 kDa) either normally sulfated (untreated),
N-desulfated (N-deS), 6-O-desulfated (6-O-deS),
or 2-O-desulfated (2-O-deS) was immobilized
on glycosaminoglycan-binding multiwell plates.
The wells were then incubated with FLAG-tagged
TIMP-3 (0.08–10 nM) (D) or FLAG-tagged
ADAMTS-5 (0.16–20 nM) (E). Bound protein was
detected using M2 anti-FLAG primary antibody
and a horseradish peroxidase-coupled secondary
antibody.
(F) TIMP-3 (0.5 nM) and ADAMTS-5 (0.5 nM) were
incubated (1 hr, 37C) with various concentrations
(10–2000 nM disaccharide) of dp36 (12.5 kDa)
heparin, either normally sulfated (untreated), N-
desulfated, 6-O-desulfated, or 2-O-desulfated
The residual activity against the fluorescent pep-
tide substrate was determined.
(G and H) Heparin of dp36 (untreated) or glycol-split dp36 heparin (60 mM disaccharide) were immobilized on glycosaminoglycan-binding multiwell plates, and
the wells were then incubated with FLAG-tagged TIMP-3 (0.08–10 nM) (G) or FLAG-tagged ADAMTS-5 (0.16–20 nM) (H). Bound protein was detected using M2
anti-FLAG primary antibody and a horseradish peroxidase-coupled secondary antibody.
(I) TIMP-3 (0.5 nM) and ADAMTS-5 (0.5 nM) were incubated (1 hr, 37C) with various concentrations (10–2000 nM disaccharide) of dp36 heparin (untreated) or
glycol-split dp36 heparin. The residual activity against the fluorescent peptide substrate was determined.
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Matrix Glycans Augment TIMP-3 Levels and Activityet al., 2007), and neuronal plasticity (Dick et al., 2013). It
is intriguing to consider whether E-type CS disaccharide units
may modulate TIMP-3 levels and activity in the brain. Our study
implies that, rather than TIMP-3 exerting a protective effect on an
inert extracellular matrix, the two have a symbiotic relationship,
with changes in one bringing about changes in the other. This
concept is likely to be of importance not only in cartilage
but also in other physiological and pathological settings, such
as wound healing, atherosclerosis, fibrosis, and cancer, with
TIMP-3 and the sulfation pattern of glycosaminoglycans being
important modulators of ECM turnover.
SIGNIFICANCE
Elucidation of the molecular mechanisms by which sulfated
glycans affect protein activity is likely to be beneficial in
understanding and modulating the behavior of many ECM-
binding growth factors and biologically active proteins in a
range of pathological conditions. In this study, we demon-
strated that catabolism of the ECM is modulated by its
own sulfation because this alters the extracellular levels
and inhibitory activity of TIMP-3, a pivotal inhibitor of ma-
trix-degrading metalloproteinase. HS and CSE selectivelyChemistry & Bincrease TIMP-3 levels in the matrix by inhibiting its binding
to the endocytic receptor LRP-1 and subsequent degrada-
tion. These sulfated glycans also increase TIMP-3 affinity
for a subset of ECM-degrading target metalloproteinases
by reducing dissociation rate constants of the TIMP-3-met-
alloproteinase complexes. Our study suggests that syn-
thetic glycan mimetics that similarly increase the TIMP-3
amount and activity in the extracellular environment would
be potential lead compounds for the development of thera-
pies to treat osteoarthritis and other diseases associated
with increased ECM-degradingmetalloproteinase activities.
EXPERIMENTAL PROCEDURES
Materials
C-terminally FLAG-tagged human TIMP-3 (Troeberg et al., 2009) and
ADAMTS-5 lacking the C-terminal thrombospondin domain (Gendron et al.,
2007) were prepared as before.
All glycan masses reported are average values. PPS was from Bene-
PharmaChemie. Porcine mucosal HS from Iduron had an average mass
of 22 kDa and contained highly sulfated 9 kDa and less sulfated 35 kDa
species. C-4-S, C-6-S, porcine mucosal 12.5 kDa heparin, 5 kDa low
molecular mass mucosal heparin, and 3 kDa heparin were purchased from
Sigma-Aldrich. Heparin pentasaccharide (fondaparinux sodium) was from
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Figure 6. TIMP-3 Colocalizes with Perlecan in the Pericellular Matrix of Cartilage
(A) Hip cartilage from Timp3+/+ and Timp3/mice were cryosectioned (8 mm). Sections were air-dried, fixed in ice-cold acetone, and blocked with 5% (v/v) goat
serum and 3% (w/v) bovine serum albumin in PBS. TIMP-3 was detected using rabbit anti-TIMP-3 and anti-rabbit Alexa Fluor 468. Perlecan was detected using
rat anti-perlecan and anti-rat Alexa Fluor 568. Nuclei were stained with DAPI. Scale bar, 23 mm.
(B) Knee cartilage from wild-type mice was sectioned and stained as in (A).
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N-desulfated heparin was prepared as described by Inoue and Nagasawa
(1976). 2-O-desulfated heparin was prepared by dissolving heparin in 0.2 M
NaOH and then lyophilizing (Jaseja et al., 1989). 6-O-desulfated heparin was
prepared by hydrolysis with N-methyl-N-(trimethylsilyl)trifluoroacetamide
(Kariya et al., 2000). Glycol-split heparin was prepared as described previously
(Casu et al., 2002).
CSE was purified from squid cartilage on diethylaminoethyl (DEAE)-Sepha-
dex (Habuchi et al., 1977). The 1.5 M NaCl eluate from this resin was further
fractionated by gel filtration on Sepharose CL-4B equilibrated in 0.2 M NaCl.
The eluate was pooled into three fractions, with average estimated molecular
masses of 800 kDa (fraction 1), 200 kDa (fraction 2), and 50 kDa (fraction 3).
Fractions were lyophilized, and the glycosaminoglycan content was quantified
using the Elson-Morgan color reaction. Chondroitin sulfate E frombonito was a
gift from Seikagaku. The disaccharide composition of the CSE preparations is
shown in Table S1.
M2 anti-FLAG antibody, Tween 20, DNase I, and proteinase K were from
Sigma-Aldrich. Rabbit polyclonal anti-TIMP-3 and rat anti-perlecan were
from Millipore. Anti-mouse horseradish peroxidase was from Dako. Anti-
mouse and anti-rabbit alkaline phosphatases were from Promega. 3,30,5,50-
Tetramethylbenzidine substrate was from KPL.
Glycosaminoglycan Binding Assay
Glycosaminoglycans (10 mg/ml in PBS) were applied overnight at 25C onto
heparin binding plates (BD Life Sciences). Wells were washed in TIMP buffer
(50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10 mM CaCl2, and 0.05% Brij-35)1306 Chemistry & Biology 21, 1300–1309, October 23, 2014 ª2014 Tcontaining 0.1% (v/v) Tween 20 between each subsequent incubation. Wells
were blocked with 0.2% (m/v) gelatin in TIMP buffer and then incubated with
recombinant C-terminally FLAG-tagged TIMP-3 or ADAMTS-5 (0.08–100 nM
in blocking solution, 3 hr, 37C). Bound proteins were detected using M2
anti-FLAG antibody (3 hr, 37C), followed by an anti-mouse antibody coupled
to horseradish peroxidase (1 hr, 37C). Hydrolysis of 3,30,5,50-tetramethylben-
zidine substrate was measured at 450 nm using a FLUOstar Omega (BMG
Labtech).
Analysis of TIMP-3 Endocytosis
HTB94 chondrosarcoma cells (6 3 105 cells/well in Dulbecco’s modified
Eagle’s medium [DMEM] with 10% fetal calf serum [FCS]) were washed twice
in serum-free DMEM and warmed for 1 hr at 37C in 1 ml of DMEM with 0.1%
FCS. For RAP-treated wells, RAP (1 mM)was added to cells during this incuba-
tion period. Recombinant TIMP-3-FLAG (0.5 nM) was incubated (1 hr, 37C)
either alone or with 200 mg/ml of heparin, HS, C-4-S, or bonito CSE and
then added to cells. Conditioned media were precipitated by addition of 5%
(v/v) trichloroacetic acid (TCA) (4C, 18 h). After centrifugation (13,000 rpm,
10 min, 4C), pellets were suspended in reducing SDS sample buffer,
electrophoresed on a 10% polyacrylamide gel, and immunoblotted onto
polyvinylidene fluoride. After blocking in 5% (m/v) BSA in Tris-buffered saline,
TIMP-3-FLAG was detected using M2 anti-FLAG antibody and an alkaline
phosphatase-linked secondary antibody.
To measure the accumulation of endogenous TIMP-3 in the presence of
sGAG, HTB94 chondrosarcoma cells (6 3 105 cells/well in DMEM with 10%
FCS) were washed twice in serum-free DMEM and incubated for 30 hr inhe Authors
Table 1. Chondroitin Sulfate Disaccharide Composition of
Human and Porcine Cartilage
DDiS
Human Cartilage Porcine Cartilage
nmol/mg % nmol/mg %
DDi-0S 0.006 1 0.029 4
DDi-4S 0.188 27 0.424 56
DDi-6S 0.436 63 0.246 33
DDi-diSE 0.019 3 0.009 1
DDi-diSD 0.047 7 0.043 6
Sulfated glycosaminoglycans were isolated from human or porcine
articular cartilage, fractionated by ion exchange chromatography, and
digested with chondroitinase ABC. The resulting unsaturated disaccha-
rides were analyzed by HLPC to determine the relative abundance of
the various sulfated species.
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S, or bonito CSE (100 and 200 mg/ml). Proteins were precipitated from media
by addition of 5% (v/v) TCA, electrophoresed, and immunoblotted as
described above. TIMP-3 was detected using polyclonal rabbit anti-TIMP-3
and an alkaline phosphatase-linked secondary antibody.
TIMP-3 Binding to LRP-1
LRP-1 ectodomain (5 nM, BioMac) was applied (18 hr, 4C) onto Costar 96-
well immunosorbent assay plates in TIMP buffer without Brij-35. Wells were
washed in TIMP buffer containing 0.1% (v/v) Tween 20 between each subse-
quent incubation. Wells were blocked (90 min, 37C) in 3% (m/v) bovine serum
albumin in TIMP buffer. TIMP-3 (1.5–80 nM) was preincubated (90 min, 37C)
with 200 mg/ml heparin, HS, bonito CSE, or squid CSE and then added to wells
(37C, 3 hr). Bound TIMP-3 was detected using M2 anti-FLAG antibody (2 hr,
37C) and anti-mouse antibody coupled to horseradish peroxidase (1 hr,
37C). Hydrolysis of 3,30,5,50-tetramethylbenzidine substrate was measured
at 450 nm using a FLUOstar Omega (BMG Labtech).
Analysis of TIMP-3 Affinity for ADAMTS-5
The affinity between TIMP-3 and ADAMTS-5 was measured using a steady-
state enzyme kinetic analysis (Bieth, 1995; Troeberg et al., 2012). TIMP-3 (0.5–
2nM)andADAMTS-5 (0.5nM)were incubated in TIMPbuffer (1 hr, 37C).Resid-
ualADAMTS-5activitywasmeasured (18hr,37C)using thefluorescentpeptide
substrate ortho-aminobenzoyl-Thr-Glu-Ser-GluSer-Arg-Gly-Ala-Ile-Tyr-(N-3-
[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-Lys-Lys-NH2 (20 mM, Bachem).
Endpoint fluorescence was measured using a Gemini microplate spectrofluo-
rometer (Molecular Devices), and Ki was determined from steady-state veloc-
ities by fitting the data to the tight-binding equation using Prism software
(GraphPad).
Biolayer Interferometry
TIMP-3 (200 nM) was biotinylated by incubation with EZ-Link succinimidyl 6-
(biotinamido)hexanoate (10 mM, 30 min, 25C, Thermo Fisher Scientific), and
excess biotin was removed using a PD-10 desalting column (GE Healthcare).
Biotinylated TIMP-3 was immobilized on streptavidin-coated biosensors
(20 min, 25C) using an Octet RED384 biolayer interferometer (Pall ForteBio).
To determine the affinity between TIMP-3 andADAMTS-5, TIMP-3-coated bio-
sensorswere incubatedwithADAMTS-5 (50–500 nM in TIMPbuffer), and asso-
ciation was observed for 10 min at 25C. Tips were then incubated in TIMP
buffer for a further 20 min at 25C to observe dissociation of the complex. No
binding of ADAMTS-5 to uncoated biosensors was observed. To determine
the effect of sGAG on the affinity between TIMP-3 and ADAMTS-5, TIMP-3-
coated biosensors were incubated with ADAMTS-5 (200 nM) and either PPS
(100nM),HS (100mM), bonitoCSE (10mM), or squidCSE (10mM) in TIMPbuffer.
Associationwasobserved for 10min at 25C, afterwhich tipswere incubated in
TIMP buffer for 20 min at 25C to observe dissociation of the complex. Kinetic
constants were calculated using a 1:1 binding model in ForteBio OctetRED
evaluation data analysis software. KD was calculated from equilibrium re-
sponses, and koff was calculated by determining the first-order rate constant.Chemistry & BObserved association rate constant (kobs) values were calculated by deter-
mining the second-order rate constant using GraphPad Prism, and kon was
calculated from linear regression of kobs on ADAMTS-5 concentration.
Immunofluorescence
Timp3/micewere providedbyProfessorRamaKhokha (OntarioCancer Insti-
tute). Cartilagewasavulsed from the femoral headsof 6-week-oldwild-typeand
Timp3/mice (Lecoet al., 2001) using forceps.The tissuewas frozen in optimal
cutting temperature (OCT) medium embedding matrix (CellPath) and cryosec-
tioned (8 mm). Sections were air-dried (1 hr, ambient temperature) and fixed in
ice-cold acetone (10 min, 20C). Sections were blocked with 5% (v/v) goat
serum and 3% (w/v) bovine serum albumin in PBS (1 hr, room temperature).
TIMP-3wasdetectedusingpolyclonal rabbit anti-TIMP-3 (1mg/ml) andanti-rab-
bit Alexa Fluor 488 (Molecular Probes). Perlecan was detected using rat anti-
perlecan (1 mg/ml) and anti-rat Alexa Fluor 568 (Molecular Probes). Nuclei
were stained with DAPI. Sections were viewed with a charge-coupled device
camera-equipped microscope (Nikon TE-2000) with a340 objective lens.
Disaccharide Composition Analysis of Cartilage
Human articular cartilage was obtained from knees of patients undergoing
amputation because of soft tissue sarcoma or osteosarcoma. Patients pro-
vided informed consent following approval by the Riverside Ethics Committee.
For the analysis shown, cartilage was pooled from three patients (two males,
one female, 40–51 years of age). Porcine articular cartilage was dissected
from metacarpophalangeal joints of commercially slaughtered pigs.
Lyophilized cartilage (30 mg dry weight) was suspended in 0.4 N KOH and
stirred for 18 hr at room temperature. After neutralization with acetic acid, sam-
ples were digested sequentially with DNase I (10 hr, 37C) and proteinase K
(40 hr, 45C). The enzymes were heat-inactivated (100C, 5 min), the samples
were centrifuged (13,000 rpm, 10 min, 4C), and the supernatant was precipi-
tated by addition of 3 volumes of cold ethanol containing 1.3% (m/v) potassium
acetate (on ice, 30 min). Pellets were collected by centrifugation (13,000 rpm,
10 min, 4C), dissolved in deionized water, and ethanol-precipitated a further
two times before being dissolved in deionized water. The glycosaminoglycans
were then applied to a DEAE-Sephacel resin (GE Healthcare) equilibrated in
20 mM Tris-HCl (pH 7.2). The column was washed in equilibration buffer con-
taining 0.2 M NaCl and glycosaminoglycans eluted in equilibration buffer con-
taining 2 M NaCl. The eluate was desalted by centrifugation on a Nanosep
centrifugation filter unit (3 kDa molecular weight cutoff, Pall Life Sciences).
For CS analysis, chondroitinase ABC (5 milliunits, Seikagaku) was added
to the filter cup in chondroitinase buffer (50 mM Tris-HCl [pH 7.2] and 1 mM
CaCl2). After incubation for 1 hr at 37
C, unsaturated disaccharides were
eluted by centrifugation (13,000 rpm, 20 min, 4C) and analyzed by high-per-
formance liquid chromatography (HPLC) on a Sensyu Pak Docosil column,
with elution monitored by a fluorescence detector (model RF-10AxL, Shi-
madzu). HPLC was carried out as described by Toyoda et al. (2000), with a
slightly modified elution condition. Briefly, the disaccharideswere labeled after
elution with 2-cyanoacetoamide (Wako Pure Chemicals Industries) (Anower-
E-Khuda et al., 2013).
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